Reports for NOVARTIS PHARMACEUTICALS CANADA INC

Company Name

NOVARTIS PHARMACEUTICALS CANADA INC

Totals

Shortage reports

148

Actual shortage: 3 (2%)
Anticipated shortage: 2 (1%)
Avoided shortage: 4 (3%)
Resolved: 139 (94%)

Discontinuation Reports

51

To be discontinued: 0 (0%)
Discontinued: 51 (100%)
Reversed: 0 (0%)

Late reports

34 (17%)

Overdue reports

1 (20%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOSTATIN 50MCG SOLUTION Resolved 2022-11-22 2023-02-11 175439
SANDOSTATIN 100MCG SOLUTION Resolved 2022-05-06 2023-02-11 160174
IZBA 0.003% SOLUTION Resolved 2022-04-11 2022-05-11 158479
IZBA 0.003% SOLUTION Resolved 2022-09-29 2023-01-06 170482
PAZEO 0.7% SOLUTION Resolved 2020-01-20 2020-03-31 103745
PAZEO 0.7% SOLUTION Resolved 2020-05-05 2020-05-21 114100
GILENYA 0.25MG CAPSULE Resolved 2023-04-28 2023-06-07 191077
LUTATHERA 370MBq SOLUTION Resolved 2022-05-06 2022-06-14 160113

Showing 141 to 148 of 148

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ONBREZ BREEZHALER 75MCG CAPSULE Discontinued 2022-06-29 2022-07-14 163682
ZOFRAN 4MG SOLUTION Discontinued 2022-06-29 2022-10-18 163685
BETOPTIC S 0.25% SUSPENSION Discontinued 2022-09-28 2023-01-19 170389
FORADIL DRY POWDER CAPSULES FOR INHALATION 12MCG CAPSULE Discontinued 2022-10-18 2023-01-25 172087
ZOFRAN 4MG TABLET Discontinued 2023-04-13 2023-05-08 189513
ZOFRAN 8MG TABLET Discontinued 2023-04-13 2023-05-08 189538
LIORESAL INTRATHECAL 2MG/ML 2MG SOLUTION Discontinued 2023-08-10 2023-09-19 201573
LIORESAL INTRATHECAL 0.05MG/ML 0.05MG SOLUTION Discontinued 2023-08-10 2023-09-19 201576
LIORESAL INTRATHECAL 0.5MG/ML 0.5MG SOLUTION Discontinued 2023-08-17 2023-09-19 202298
TASIGNA 50MG CAPSULE Discontinued 2023-10-19 2023-11-06 207564
SANDOSTATIN 100MCG SOLUTION Discontinued 2024-03-22 2024-03-22 223070

Showing 41 to 51 of 51